DiviDrip · RNTX

RNTX — Rein Therapeutics Inc.

RNTX is Rein Therapeutics Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.89. Market cap: $77M. Capital Quality Rank: 13/100 — Capital destroyer.

Stock snapshot

Price$0.89
Market cap$77M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)13 / 100 · Capital destroyer
Altman Z-score zoneDistress

About RNTX

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

Listed2017Employees10HQAustin, TXSectorHealthcareWebsitereintx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside RNTX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is RNTX's current stock price?

RNTX (Rein Therapeutics Inc.) is currently trading at $0.89.

Does RNTX pay a dividend?

RNTX (Rein Therapeutics Inc.) does not currently pay a regular dividend.

What is RNTX's Capital Quality Rank?

RNTX has a Capital Quality Rank of 13/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track RNTX in DiviDrip

Add RNTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow